Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 29Uterine Cervical Dysplasia 18Precancerous Conditions 5Papillomavirus Infections 5Squamous Intraepithelial Lesions 3Uterine Cervical Diseases 2Neoplasms 2Genital Diseases 2Atypical Squamous Cells of the Cervix 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Sexually Transmitted Diseases, Viral 1Sexually Transmitted Diseases 1Papilloma 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Genital Neoplasms, Female 1Genital Diseases, Female 1Female Urogenital Diseases and Pregnancy Complications 1Cervical Intraepithelial Neoplasia Grade 2/3 1Cervical Intraepithelial Neoplasia Grade 1 (CIN 1) 1Adenocarcinoma in Situ 1Acquired Immunodeficiency Syndrome 1

Interventions

anlotinib 2Bevacizumab 2trametinib 1siltuximab 1olaparib 1niraparib 1enzalutamide 1dabrafenib 1cobimetinib 1atezolizumab 1Vemurafenib 1Papanicolaou Test 1Human Papillomavirus DNA Tests 1Drug Therapy 1Colposcopy 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Histologic Type × Colposcopy × Gynecologic × Clear all
NCT01234480 2023-05-16

Intended Use Study of the BD SurePath Plusâ„¢ Pap

Becton, Dickinson and Company

Terminated
5,859 enrolled 4 charts
Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡